Pfizer expects $15 billion in 2021 sales from its COVID-19 vaccine
By Roberts in News
Updated 3 years ago
Pfizer Inc said on Tuesday it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech SE.